Skip to content
Esta página está disponible en españolCambiar →

FinVolution Group (FINV): which funds own it

Financials →(by SIC code, unreviewed)Data as of Jun 30, 2026 (Q2 2026) · updated on Nov 6, 2026

A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.

Sections with a free account

No concentrated manager holds it.

Who owns FinVolution Group?

FinVolution Group trades in the U.S. through ADRs, certificates that represent shares of a non-U.S. company. Form 13F counts ADRs while the company reports ordinary shares, so we do not compute percentages. Holders reporting more than 5% of the ordinary shares to the SEC (Schedules 13D/13G): Shaofeng Gu, 35.3% (13D/A filed Jan 12, 2026), Susquehanna Securities, 13.5% (13G/A filed Aug 14, 2026) and Sun Hung Kai, 5.6% (13G/A filed May 8, 2025). As of Jun 30, 2026, the largest ADR holders reported on Form 13F were Susquehanna International Group, LLP (16.5 million ADRs), Invesco (6.0 million ADRs) and Bank of America (4.2 million ADRs).

Which institutions hold the most FinVolution Group shares?

Per Form 13F filings as of Jun 30, 2026, in ADRs:

  1. 1. Susquehanna International Group, LLP: 16.5 million ADRs
  2. 2. Invesco: 6.0 million ADRs
  3. 3. Bank of America: 4.2 million ADRs
  4. 4. Vanguard Capital Management: 3.3 million ADRs
  5. 5. BlackRock: 2.6 million ADRs
  6. 6. Morgan Stanley: 2.5 million ADRs
  7. 7. Acadian Asset Management: 2.5 million ADRs
  8. 8. Causeway Capital Management: 2.3 million ADRs
  9. 9. Dimensional Fund Advisors: 2.0 million ADRs
  10. 10. Goldman Sachs Group: 1.7 million ADRs

Sources:13D/A by Shaofeng Gu (Jan 12, 2026) ↗13G/A by Susquehanna Securities (Aug 14, 2026) ↗13G/A by Sun Hung Kai (May 8, 2025) ↗All of the company's proxy statements on EDGAR ↗

We hold 13D and 13G filings made since Dec 23, 2024: a holder above 5% that has not filed since then does not appear here.

FinVolution Group revenue

FinVolution Group reported annual revenue of $1.77 billion for fiscal year 2023 (year ended December 31, 2023), according to its Form 20-F filed with the SEC (XBRL data).

Concentrated managers
—
All 13F: 124
Consensus
—
No score: it needs 5 or more concentrated managers
Price at Jun 30, 2026 (per 13F)
$4.79
-0.0% in the quarter · reported value ÷ shares, not the quote · See current quote ↗

Quarter flow (concentrated managers)

Concentrated managers holding it

None in the latest quarter.

Largest holders of FINV (all 13F filers)

The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.

Fundamentals

12-month figures to Dec 31, 2025.

Profitability
Operating margin
—
Net margin
—
ROE
15.4%
Growth
Revenue (TTM)
—
Revenue growth
—
Net income (TTM)
$364M
Balance sheet
Quality vs sector
—

Bank, insurer or other financial company: we do not show net debt / EBITDA or free cash flow. Its cash flow moves with loans and the investment portfolio, and its debt is part of the business: those figures do not read as they do for an industrial company.

This company's sector comes from its SIC code, unreviewed, or has too few comparable companies: we do not compare it with its sector.

Figures from the statements the company filed with the SEC (10-K, 10-Q). Free cash flow = operating cash flow − capital expenditures; empty if the company does not report capex. “Quality vs sector”: 0 to 100, the average of its percentiles in ROE, operating margin, free-cash-flow margin, revenue and earnings growth and net debt / EBITDA (at least 3 needed) against companies in its sector above $300M. How each figure is calculated

Shares outstanding: buybacks and dilution

Diluted shares by fiscal year (split-adjusted)

2025: 1.33 bn

1.60 bn0
20172025

There is a jump that may be an undetected split: we do not show the changes.

Buybacks (FY 2025)
$110M
Share issuance
no data
Stock-based compensation
$21.3M
Dividends paid
$73.0M

From the statements the company filed with the SEC (10-K). The change compares average diluted shares of each fiscal year, on today's basis: negative = it bought back more than it issued; positive = dilution. “No data” = the company does not report that item under a tag we can read; it does not mean zero.

Earnings quality and debt

Operating cash flow ÷ net income (12 months)
0.73

Bank or insurer: debt ratios do not apply.

From the figures the company filed with the SEC. Cash flow over net income near or above 1 means earnings are collected in cash; far below, that part is accounting. Coverage says how many times operating income pays the latest fiscal year's interest. Maturities come from the debt note of the latest annual report, counted from its closing date. “No data” never means zero.

Insiders (Form 4)

Officers and directors who bought (6 m)
0
Amount (6 m)
$0
CEO/CFO bought (12 m)
No

10% owners who bought (6 m): 0

Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.

Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →

Above 5% (13D/13G)

Disclosed stakes, with their amendments. A filing is not always a purchase: there are also reductions and changes of filing entity.

This list may be incomplete: we hold 13D and 13G filings made since Dec 23, 2024. A holder above 5% that has not filed anything since then is not shown here.

  • Susquehanna Securities13.5%13G · amendmentfiling ↗Event: Jun 30, 2026 · filed: Aug 14, 2026
  • Shaofeng Gu35.3%13D · amendmentfiling ↗Event: Dec 31, 2025 · filed: Jan 12, 2026
  • Sun Hung Kai5.6%13G · amendmentfiling ↗Event: Mar 31, 2025 · filed: May 8, 2025

Above 5% over time (13D/13G)

Each holder with its filings in order. History since December 2024.

This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗

Other Financials stocks in managers' portfolios

Same sector and a similar number of concentrated managers holding them. It is a list to keep exploring, not a recommendation.

All of Financials →

Follow FINV for free

If someone reports a 5%+ stake, we email you (if you turn it on). And when you come back, see whether concentrated managers got in or out. No credit card.

Follow FINV